XML 13 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Pain In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2023 $ 170,175 $ 4 $ 550,943 $ (380,772)  
Balance, shares at Dec. 31, 2023   43,270,386      
Issuance of common stock upon exercise of stock options 189   189    
Issuance of common stock upon exercise of stock options, shares   88,283      
Issuance of common stock upon vesting of restricted stock, shares   148,980      
Shares withheld for taxes (141)   (141)    
Shares withheld for taxes, shares   (67,813)      
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Amount 19,266 $ 1 19,265    
Issuance of common stock pursuant to at-the-market offering, net of issuance costs of $0.6 million, Share   6,350,000      
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Amount 91,652 $ 3 91,649    
Issuance of common stock and pre-funded warrants pursuant to underwritten public offering, net of issuance costs of $6.3 million, Share   32,379,667      
Stock-based compensation expense 5,679   5,679    
Net Income (Loss) (28,016)     (28,016)  
Balance at Mar. 31, 2024 258,804 $ 8 667,584 (408,788)  
Balance, shares at Mar. 31, 2024   82,169,503      
Balance at Dec. 31, 2023 170,175 $ 4 550,943 (380,772)  
Balance, shares at Dec. 31, 2023   43,270,386      
Net Income (Loss) (57,917)        
Balance at Jun. 30, 2024 235,111 $ 8 673,792 (438,689)  
Balance, shares at Jun. 30, 2024   82,400,960      
Balance at Mar. 31, 2024 258,804 $ 8 667,584 (408,788)  
Balance, shares at Mar. 31, 2024   82,169,503      
Issuance of common stock upon exercise of stock options 6   6    
Issuance of common stock upon exercise of stock options, shares   4,000      
Issuance of common stock upon vesting of restricted stock, shares   35,400      
Purchase of common stock under Employee Stock Purchase Plan 198   198    
Purchase of common stock under Employee Stock Purchase Plan Shares   192,057      
Stock-based compensation expense 6,004   6,004    
Net Income (Loss) (29,901)     (29,901)  
Balance at Jun. 30, 2024 235,111 $ 8 673,792 (438,689)  
Balance, shares at Jun. 30, 2024   82,400,960      
Balance at Dec. 31, 2024 186,609 $ 8 684,479 (497,894) $ 16
Balance, shares at Dec. 31, 2024   82,569,168      
Issuance of common stock upon vesting of restricted stock, shares   256,913      
Shares withheld for taxes (104)   (104)    
Shares withheld for taxes, shares   (116,456)      
Other comprehensive income (25)       (25)
Stock-based compensation expense 3,180   3,180    
Net Income (Loss) (28,214)     (28,214)  
Balance at Mar. 31, 2025 161,446 $ 8 687,555 (526,108) (9)
Balance, shares at Mar. 31, 2025   82,709,625      
Balance at Dec. 31, 2024 $ 186,609 $ 8 684,479 (497,894) 16
Balance, shares at Dec. 31, 2024   82,569,168      
Issuance of common stock upon exercise of stock options, shares 0        
Net Income (Loss) $ (59,431)        
Balance at Jun. 30, 2025 133,372 $ 8 690,730 (557,325) (41)
Balance, shares at Jun. 30, 2025   83,252,520      
Balance at Mar. 31, 2025 161,446 $ 8 687,555 (526,108) (9)
Balance, shares at Mar. 31, 2025   82,709,625      
Issuance of common stock upon vesting of restricted stock, shares   29,500      
Purchase of common stock under Employee Stock Purchase Plan 267   267    
Purchase of common stock under Employee Stock Purchase Plan Shares   513,395      
Other comprehensive income (32)       (32)
Stock-based compensation expense 2,908   2,908    
Net Income (Loss) (31,217)     (31,217)  
Balance at Jun. 30, 2025 $ 133,372 $ 8 $ 690,730 $ (557,325) $ (41)
Balance, shares at Jun. 30, 2025   83,252,520